In 2002 the Italian Society for the Study of Headaches (SISC) introduced a second version of guidelines (GL) aimed to determine the most appropriate choice of drugs for the therapy of migraine. The impact of preventative GL in the general practice had been assessed in 1999, when drug use was evaluated respectively before (1989-92, n 351) and after (1995-98, n 204) the introduction of 1993 GL. Our aim was to establish the impact in migraine patients using the 2002 SISC GL. The common use of migraine preventative drugs in current clinical practice differs in many aspects from the 2002 SISC GL. Very relevant is the fact that the number of patients who, despite having the indication for preventative treatment are not receiving it, is very high (58.3%) and remains substantially unchanged during the years. A more adequate diffusion of the just published 2011 GL should be planned in order to effectively impact current practice. Furthermore, the promotion of the use of a headache diary could improve the therapeutic choice when a preventative strategy is being considered.

The use of migraine preventative drugs on current clinical practice. An analysis based on a series of 400 patients / M., Bellamio; M., Margoni; Pini, Luigi Alberto; C., Lisotto; C., Disco; F., Maggioni; G., Zanchin. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S54-S54. (Intervento presentato al convegno XXVI National Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond tenutosi a Modena nel 26-28 October 2012).

The use of migraine preventative drugs on current clinical practice. An analysis based on a series of 400 patients

PINI, Luigi Alberto;
2012

Abstract

In 2002 the Italian Society for the Study of Headaches (SISC) introduced a second version of guidelines (GL) aimed to determine the most appropriate choice of drugs for the therapy of migraine. The impact of preventative GL in the general practice had been assessed in 1999, when drug use was evaluated respectively before (1989-92, n 351) and after (1995-98, n 204) the introduction of 1993 GL. Our aim was to establish the impact in migraine patients using the 2002 SISC GL. The common use of migraine preventative drugs in current clinical practice differs in many aspects from the 2002 SISC GL. Very relevant is the fact that the number of patients who, despite having the indication for preventative treatment are not receiving it, is very high (58.3%) and remains substantially unchanged during the years. A more adequate diffusion of the just published 2011 GL should be planned in order to effectively impact current practice. Furthermore, the promotion of the use of a headache diary could improve the therapeutic choice when a preventative strategy is being considered.
2012
13
S54
S54
M., Bellamio; M., Margoni; Pini, Luigi Alberto; C., Lisotto; C., Disco; F., Maggioni; G., Zanchin
The use of migraine preventative drugs on current clinical practice. An analysis based on a series of 400 patients / M., Bellamio; M., Margoni; Pini, Luigi Alberto; C., Lisotto; C., Disco; F., Maggioni; G., Zanchin. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - STAMPA. - 13:(2012), pp. S54-S54. (Intervento presentato al convegno XXVI National Congress of the Italian Society for the Study of Headaches. Pharmacological therapies and beyond tenutosi a Modena nel 26-28 October 2012).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/851711
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact